Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.93NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.128NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.640NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
BA.2.86.4NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.1.168NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.177.83NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.420NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
AY.79 (Delta)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
BA.2.33NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.1.318NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.177.49NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
AZ.2.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
AZ.4NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.167NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.267NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.444NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.537NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.548NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.524NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.1.74NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-5544.17Germany
B.1.160.26NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-5544.17Germany
XBF.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-5579.54China
B.1.6NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-5669.88US
B.1.177.49NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-5669.88US
B.1.444NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-5669.88US
B.1.537NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-5669.88US
B.1.258.23ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
BA.5.2.47ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
BS.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
BA.5.1.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
B.1.1.92ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
BA.2.61ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
BA.5.1.23ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
BA.5.8ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
XFORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
BA.5.2.42ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
XBC.1.1.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
B.1.1.396ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
B.1.531ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
B.1.1.149ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
B.1.491ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
JJ.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
XCHORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
GK.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
XBB.1.16.17ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
CP.8ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
XBB.1.11.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
XBB.1.5.80ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
GG.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
BA.1.1.5ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used